Roche and Broad Clinical Labs are collaborating to develop applications using Roche's SBX sequencing technology. The initial focus is on whole genome sequencing of critically ill newborns and their parents to aid in diagnosis of genetic disorders. This project aims to integrate this technology into routine neonatal care. The SBX technology offers fast, scalable, and cost-effective sequencing. The collaboration will explore applications in RNA sequencing and other research areas. Broad Clinical Labs will utilize the technology for both clinical and research purposes. The SBX technology's speed and scalability are key benefits for time-sensitive settings. Both organizations share a vision for genomics-enabled healthcare and advancing precision medicine. The partnership leverages Broad's expertise in genomics and Roche's innovative SBX technology. The ultimate goal is to improve patient outcomes through rapid and accurate genetic diagnoses.